Literature DB >> 21862411

Iron disorders of genetic origin: a changing world.

Pierre Brissot1, Edouard Bardou-Jacquet, Anne-Marie Jouanolle, Olivier Loréal.   

Abstract

Iron disorders of genetic origin are mainly composed of iron overload diseases, the most frequent being HFE-related hemochromatosis. Hepcidin deficiency underlies iron overload in HFE-hemochromatosis as well as in several other genetic iron excess disorders, such as hemojuvelin or hepcidin-related hemochromatosis and transferrin receptor 2-related hemochromatosis. Deficiency of ferroportin, the only known cellular protein iron exporter, produces iron overload in the typical form of ferroportin disease. By contrast, genetically enhanced hepcidin production, as observed in matriptase-2 deficiency, generates iron-refractory iron deficiency anemia. Diagnosis of these iron storage disorders is usually established noninvasively through combined biochemical, imaging and genetic approaches. Moreover, improved knowledge of the molecular mechanisms accounting for the variations of iron stores opens the way of novel therapeutic approaches aiming to restore normal iron homeostasis. In this review, we will summarize recent findings about these various genetic entities that have been identified owing to an exemplary interplay between clinicians and basic scientists.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862411     DOI: 10.1016/j.molmed.2011.07.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  14 in total

1.  SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its intracellular trafficking and efflux activity.

Authors:  Dinorah Leyva-Illades; Pan Chen; Charles E Zogzas; Steven Hutchens; Jonathan M Mercado; Caleb D Swaim; Richard A Morrisett; Aaron B Bowman; Michael Aschner; Somshuvra Mukhopadhyay
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

2.  Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals.

Authors:  Anthony S Grillo; Anna M SantaMaria; Martin D Kafina; Alexander G Cioffi; Nicholas C Huston; Murui Han; Young Ah Seo; Yvette Y Yien; Christopher Nardone; Archita V Menon; James Fan; Dillon C Svoboda; Jacob B Anderson; John D Hong; Bruno G Nicolau; Kiran Subedi; Andrew A Gewirth; Marianne Wessling-Resnick; Jonghan Kim; Barry H Paw; Martin D Burke
Journal:  Science       Date:  2017-05-12       Impact factor: 47.728

3.  Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis.

Authors:  Emilio Ramos; Piotr Ruchala; Julia B Goodnough; Léon Kautz; Gloria C Preza; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

Review 4.  Manganese homeostasis in the nervous system.

Authors:  Pan Chen; Sudipta Chakraborty; Somshuvra Mukhopadhyay; Eunsook Lee; Monica M B Paoliello; Aaron B Bowman; Michael Aschner
Journal:  J Neurochem       Date:  2015-06-16       Impact factor: 5.372

5.  Hemochromatosis: a model of metal-related human toxicosis.

Authors:  Pierre Brissot; Thibault Cavey; Martine Ropert; François Gaboriau; Olivier Loréal
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-15       Impact factor: 4.223

Review 6.  Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology.

Authors:  Tina Skjørringe; Annette Burkhart; Kasper Bendix Johnsen; Torben Moos
Journal:  Front Mol Neurosci       Date:  2015-06-08       Impact factor: 5.639

Review 7.  Iron, hepcidin, and the metal connection.

Authors:  Olivier Loréal; Thibault Cavey; Edouard Bardou-Jacquet; Pascal Guggenbuhl; Martine Ropert; Pierre Brissot
Journal:  Front Pharmacol       Date:  2014-06-04       Impact factor: 5.810

8.  Novel bioimaging techniques of metals by laser ablation inductively coupled plasma mass spectrometry for diagnosis of fibrotic and cirrhotic liver disorders.

Authors:  Pornwilard M-M; Ralf Weiskirchen; Nikolaus Gassler; Anja K Bosserhoff; J Sabine Becker
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

Review 9.  Molecular basis of HFE-hemochromatosis.

Authors:  Maja Vujić
Journal:  Front Pharmacol       Date:  2014-03-11       Impact factor: 5.810

10.  EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH).

Authors:  Graça Porto; Pierre Brissot; Dorine W Swinkels; Heinz Zoller; Outi Kamarainen; Simon Patton; Isabel Alonso; Michael Morris; Steve Keeney
Journal:  Eur J Hum Genet       Date:  2015-07-08       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.